Has COVID-19 made paying for your medicine a challenge? AbbVie may be able to help. Call 1.800.4HUMIRA or tapclick to learn more
Complete the form below to receive informational emails and mailings to help you better understand your ulcerative colitis and treatment options.
* Denotes a required field.
We ask for your email address so that we can send you information about your condition and HUMIRA.
We ask for your mailing address so that we can send you information about your condition and HUMIRA.
We ask for your date of birth to ensure that you are 18 years of age or older, and to help us recognize your registration record.
Currently Taking Medication(s). Please check all that apply.*
†(e.g., Azulfidine (sulfasalazine), Asacol® (mesalamine), Pentasa® (mesalamine), Lialda® (mesalamine), Rowasa® (mesalamine), ColazaI® (balsalazide disodium))
‡(e.g., xImuran (azathioprine), Purinethol® (mercaptopurine))
‡(e.g., Imuran (azathioprine), Purinethol® (mercaptopurine))
All trademarks are the property of their respective companies.
By clicking Submit, I agree to the following:
I would like to receive news and updates about AbbVie’s products, clinical trials, research opportunities, programs, and other information that may be of interest to me.
For more information about AbbVie’s privacy practices and your privacy choices, visit www.abbvie.com/privacy.html.